Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.49 EUR | +0.15% | +6.05% | -2.26% |
05-22 | Transcript : Nanobiotix S.A., Q1 2024 Earnings Call, May 22, 2024 | |
05-22 | Nanobiotix: strategy update, share price declines | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 331M | |
+51.81% | 58.06B | |
-4.78% | 40.53B | |
+37.21% | 38.99B | |
+13.40% | 26.7B | |
-12.01% | 26.56B | |
-21.47% | 18.98B | |
+1.37% | 12.17B | |
+23.68% | 12B | |
+26.89% | 11.92B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment